Here are the biggest calls on Wall Street on Monday: Jefferies upgrades Fastenal to buy from hold Jefferies says the stock is best positioned in 2026. "We upgrade Fastly to Overweight with an upside price target of $14." JPMorgan upgrades Dollar General to overweight from neutral JPMorgan calls the stock a "consistent compounder." " DG is positioned to deliver 2-3%(+) same-store-sales multi-year supported by the company's new store waterfall & store renovations/remodels, as well as company-specific initiatives including discretionary reset & Value Valley." Macquarie initiates Pony AI at outperform Macquarie says shares of the China robotaxi company have more room to run. "Pony' s strategy to rapidly deploy robotaxis in China's Tier-1 cities looks apt as the industry remains in early days." Jefferies upgrades KLA Corp. to buy from hold Jefferies raises its price target on KLA Corp to $1,500 per share from $1,200. "AI continues to drive spend with WFE [wafer fab equipment] accelerating into C26/C27. Given the outsized exposure to the Leading Edge and recent relative multiple reset as premium closing vs peers, we raise PT to $1,500." Bank of America upgrades Bristol-Meyers to buy from neutral Bank of America likes the company's R & D pipeline. "We upgrade Bristol-Myers Squibb (BMY) to a Buy rating from Neutral and raise our price objective to $61/shr from $52/shr), based on a 10x P/E multiple applied to FY27E EPS." Wedbush reiterates Tesla as outperform Wedbush says it's sticking with the stock heading into 2026. "In a nutshell, we believe Tesla is taking major steps in advancing its AI Revolution path with autonomous and robotics front and center heading into 2026 that will be a "game changer and define Tesla's future". We maintain our OUTPERFORM rating and $600 price target" UBS initiates Waystar at buy UBS sees robust growth ahead for the cloud management platform system. "We initiate coverage of Waystar (WAY) with a Buy rating and a price target of $41. Waystar is a leading cloud-native revenue cycle management (RCM) platform, positioned to capture a multi-year secular shift toward automation, electronic transactions, and AI-enabled workflows across provider organizations." UBS initiates Valley National Bank at buy UBS says there's "clear visibility" for the New Jersey-based regional bank. "We initiate coverage of VLY with a Buy rating and a $15 price target." Morgan Stanley upgrades Doximity to overweight from equal weight Morgan Stanley says buy the dip in the healthcare tech company. "Underperformance in DOCS is at odds with our checks on the business and strengthening platform engagement." Read more. JPMorgan upgrades IMAX to overweight from neutral JPMorgan upgrades the movie stock following its investor day. "We're upgrading IMAX to Overweight (from Neutral) and moving to a Dec-26 PT of $47. This month's investor day — where we had a chance to speak with the company's operating team — and recent fundamental performance have crystallized for us the change in IMAX's position within the exhibition market." Goldman Sachs lifts Marriott to buy from neutral Goldman says the stock is best positioned heading into 2026. "We upgrade Marriott International to Buy from Neutral, as the company is one of the best positioned in our coverage to benefit from ongoing relative strength in the higher end consumer, International and Group/Leisure..." Goldman Sachs upgrades Las Vegas Sands to buy from neutral Goldman sees "sustained momentum" at LVS. Indeed, our excess liquidity analysis implies that LVS could repurchase ~30% of its current market cap (~$13bn), if it were to flex its balance sheet to ~3x net leverage (which is still comfortably below peers). Read more. Bernstein reiterates Nvidia as outperform Bernstein says it's sticking with Nvidia following a series of investor meetings. "The datacenter opportunity is enormous, and still early, with material upside still possible." KeyBanc downgrades Adobe to underweight from sector weight The bank says margin outperformance will be tough. "Downgrading Adobe to Underweight again, the either/or trade-off of growth and margin tells us outperformance may prove difficult." KeyBanc raises Trane Technologies to overweight from sector weight Key says buy the dip in the HVAC company. "We are upgrading shares of TT to OW with a $500 PT." KeyBanc downgrades ServiceNow to underweight from sector weight The bank sees worrying back-office trends. "We are downgrading ServiceNow to Underweight and establishing a $775 price target." Bank of America initiates Central Bancompany at buy Bank of America calls the regional bank "high quality." "We initiate coverage of Central Bancompany (CBC) with a Buy rating and $27 PO, implying 18% potential upside." Morgan Stanley upgrades Hershey to overweight from equal weight Morgan Stanley says the chocolate stock is undervalued. "We upgrade HSY to OW with ~20% total return including a ~3% yield, as the stock offers rare visibility into significant EPS growth within staples." Roth downgrades Costco to sell from neutral The firm says competition is getting tougher for Costco. "Despite a 1Q earnings beat, underlying metrics are concerning: 1) renewal rates are fading; 2) paid members have slowed, possibly negative q/q (adjusted for openings); and 3) y/y comp traffic is decelerating." Deutsche Bank upgrades McCormick to buy from hold Deutsche says the spice maker is a top idea in 2026. "While MKC trades at a notable premium to the average Staples company and certainly to the average Food company, we see this valuation premium3 as warranted due to MKC's exposure to the more stable growth spice/seasoning/extracts/flavors/heat categories, its structural sourcing-driven competitive advantages within these categories, and its diversified exposure to channels including Food Away from Home" BTIG upgrades Enersys to buy from hold BTIG says the battery manufacturer is a key provider of data center technology. "We upgrade Enersys (ENS, Buy, $175 PT) on the back of improving demand for its backup battery and power solutions for telecom, industrial power, and data centers." Wells Fargo upgrades Masco to overweight from equal weight Wells says the building products company has a reasonable valuation. "We upgrade MAS to Overweight today simply because it's one of the lowest beta ways to play the group, which we like amidst uncertainty..." Jefferies upgrades Viking Holdings to buy from hold Jefferies sees sustained growth for the luxury cruise company. "Upgrading VIK on Visible Growth and Business Model Strength & Positioning." Read more. Goldman Sachs initiates SiTime at buy Goldman says the silicon-based precision timing solutions company is a data center beneficiary. "We initiate coverage of SITM with a Buy rating and a 12-month price target of $420." Goldman Sachs downgrades Texas Instruments to sell from buy Goldman sees "lackluster execution." "We downgrade Texas Instruments to Sell from Buy given lackluster execution through the cycle, and less leverage than peers in the upcycle we see ahead." Goldman Sachs downgrades Arm to sell from neutral Goldman sees limited upside. "We downgrade ARM H oldings to Sell from Neutral given limited leverage to the AI cycle, traction across non-traditional markets, and business model transition." Goldman Sachs upgrades Teradyne to buy from sell Goldman says the semiconductor equipment testing company has plenty of upside. "We upgrade Teradyne to Buy from Sell as we believe the company will gain greater traction in GPU testing, plus recovery in traditional customers." Jefferies upgrades Trex to buy from hold Jefferies says the building products company is at an attractive entry point. "We're upgrading TREX to a Buy & raising our PT to $42." Susquehanna initiates Fabrinet at positive Susquehanna says the semiconductor optical manufacturer is well positioned. "Initiating coverage on Fabrinet, a leader in transceiver contract manufacturing and a key NVIDIA supply partner with proliferating opportunities in AI infrastructure." Bank of America upgrades Charles River to buy from neutral Bank of America says the life sciences company has "early research exposure." " CRL is likely the preferred way to get exposure to early stage Pharma R & D. The company is also making good progress on cost-cutting / strategic review process" Bank of America names Thermo Fisher a top pick Bank of America sees improving spend for the life sciences company in 2026. "our top pick is TMO , given its strong ties with biopharma and multiple business lines that stand to benefit from improved Pharma spend." Evercore ISI initiates Honeywell at outperform Evercore says 2026 will be a pivotal year for the stock. " HON has the richest catalyst path of the stocks we cover..." Evercore ISI initiates GE Vernova at outperform Evercore says GE Vernova shares are not cheap but that it has robust growth. "It's expensive, but you get what you pay for. > 10% org revenue growth 2025-28E, 1,000bps of margin expansion & prospect of ongoing capital returns." Wolfe downgrades AT & T to peer perform from outperform The researcher says AT & T has a lack of visibility right now on the stock. "We downgrade T to Peer Perform on a 'wait and see' approach to ARPU in a changing market." Evercore ISI reiterates Apple as outperform Evercore says the stock remains a top idea in 2026 and that shares are compelling for the long haul. "AAPL: Attractive LT opportunity driven by long-tailed upgrade cycle (new iPhone form factor), AI tailwinds from a smarter Siri, monetization opportunity with 3rd party across 1.5B+ install base, solid growth in Wearables and Service, and strong margins."
